ArticleNature communications2025

Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa.

Andrew Phillips et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.